Levaquin Archives - Carey Danis & Lowe

FDA Levaquin Warning: Serious Side Effects Could Become Permanent

By | Levaquin, Uncategorized

In mid-May 2016, the US Food and Drug Administration (FDA) issued a new safety warning about Levaquin (fluoroquinolone). The regulatory agency warned of serious side effects that could become permanent.

Levaquin side effects mentioned in the warning include:

  • Tendon, joint, and muscle pain
  • “Pins and needles” prickling sensation
  • Confusion
  • Hallucinations

According to the FDA, these side effects can occur simultaneously, and can become permanent.

With this new information, the FDA ordered that drug labels for Levaquin and other fluoroquinolone drugs be updated.

We are here to help you.

Do you have a Levaquin case? We can help you determine if filing a Levaquin lawsuit is the right decision. Our law firm offers free, no obligation case evaluations.

Contact Carey Danis & Lowe today. Call 800.721.2519, or complete our confidential online form.

FDA Releases Safety Communication about Levaquin & Peripheral Neuropathy

By | Levaquin, Pharmaceutical litigation, Uncategorized

Antibiotic Levaquin Tendon Rupture Tendinitis LawsuitThe U.S. Food and Drug Administration (FDA) recently ordered that an update be made to the drug labels for fluoroquinolone medications, which includes the antibiotic drug Levaquin. Released on August 15, 2013, the FDA’s safety communication calls for improved information on a fluoroquinolone side effect, peripheral neuropathy.

The FDA states that peripheral neuropathy is a severe form of nerve damage that has the potential to permanently injure patients. If patients taking a fluoroquinolone drug, such as Levaquin, begin to notice peripheral neuropathy symptoms, the FDA recommends stopping use of the medication and seeking assistance from a health care provider. Peripheral neuropathy symptoms include pain, numbness, and tingling in the arms, hands, legs, and feet.

Updating the medication guide for fluoroquinolone drugs to include not only information about peripheral neuropathy will provide patients with important safety information that has the potential to prevent future injuries.

Levaquin is primarily known for causing tendon damage. Carey Danis & Lowe Levaquin lawsuit attorneys provide legal counsel to individuals who claim to have experienced either tendon tears or tendon ruptures associated with Levaquin use. Other tendon complications linked to Levaquin use include tendonitis, tendon inflammation, and joint immobility.

Carey Danis & Lowe is currently accepting Levaquin lawsuits. For a free legal evaluation of your Levaquin case and for advice from a nurse, contact Carey Danis & Lowe by calling 800.721.2519 or by submitting a personal injury claim form.

Levaquin Lawsuit News: Antibiotic Drug Levaquin Linked to Tendon Damage and Many Other Serious Side Effects

By | Levaquin, Pharmaceutical litigation, Uncategorized

Levaquin MDL Settlement Update: Phase 1 Plaintiffs Have Signed a Settlement AgreementIn current Levaquin lawsuit news, it has become apparent that fluoroquinolones, like Levaquin (levofloxacin), is the cause of more than just tendon damage, as previously understood. In a recent New York Times article,  fluoroquinolone antibiotics have recently been linked to other serious problems affecting ocular and renal health.

The article goes on to cite the fact that this class of antibiotics has been over-prescribed by doctors. According to one pharmacological epidemiologist, prescribing a drug like Levaquin to treat certain infections is sometimes overkill. It appears that the harm caused by Levaquin and other fluoroquinolone antibiotics could be lessened by exploring other treatment options.

Individuals who have taken Levaquin, and have experienced health complications following use, have most often reported incidences of tendon damage, tendon rupture, and tendonitis. Though, in addition to tendon problems, recent research published in The Journal of the American Medical Association reveals that the use of fluoroquinolones like Levaquin has also played a key role in increasing the risk of retinal detachment and kidney failure.

In 2008, the U.S. Food and Drug Administration ordered manufacturers of fluoroquinolones to include a boxed warning about the risk of developing tendonitis and tendon damage while using these kinds of antibiotics. Following the studies showing a connection between Levaquin and damage to retinal and renal health, the FDA recently updated this order to cover information about the link between fluoroquinolone use and neuromuscular problems.

The manufacturer of Levaquin, Janssen Pharms, faces over 2,000 Levaquin lawsuits.

Carey Danis & Lowe Levaquin lawyers are currently investigating Levaquin cases. If you or someone you love has been injured through the use of Levaquin, contact Carey Danis & Lowe today for a free legal evaluation and for assistance in filing a Levaquin lawsuit.

Contact Carey Danis & Lowe by calling 800.721.2519 or by submitting a personal injury claim form.

Levaquin MDL Settlement Update: Phase 1 Plaintiffs Have Signed a Settlement Agreement

By | Levaquin, Pharmaceutical litigation, Uncategorized

Levaquin MDL Settlement Update: Phase 1 Plaintiffs Have Signed a Settlement AgreementCourt convened on January 8, 2013 for a Status Conference for Levaquin lawsuits that have been consolidated into In Re: Levaquin Products Liability Litigation, the Multi-District Litigation (MDL) that is being heard by U.S. District Judge John R. Tunheim in the U.S. District Court for the District of Minnesota. Though the plaintiffs’ committee and the defendant’s representation only met for a half hour, they brought forth important updates in the Levaquin MDL.

According to information provided by the Defendants, there are currently 1000 cases pending in the Levaquin MDL “that are in the process of settling, and will soon be dismissed.” Once the settlement of these 1000 cases is complete, the Levaquin MDL will consist of 900 cases.

In state Levaquin lawsuits, there is a mass tort litigation that has been established in a New Jersey state court with 1400 cases that remain open. Further updates about the New Jersey mass tort Levaquin litigation will be available after the next Status Conference, which is scheduled for January 25. To date, the New Jersey mass tort Levaquin litigation represents the most Levaquin lawsuits being heard by a state court.

As the Levaquin MDL Status Conference minutes detail, there are “three cases pending in Illinois…one case in Pennsylvania and one in Mississippi.”

As to the status of settlement negotiations in the Levaquin MDL, both parties have come to a settlement agreement in Phase 1 cases. The plaintiffs with cases consolidated into the Phase 1 pool have signed the settlement agreement.

The plaintiffs’ committee has since begun work on plans to allocate the settlement funds. For cases consolidated into Phase 2 and Phase 3 pools, both parties are still working on negotiating a settlement agreement.

Levaquin is a drug manufactured by OrthoMcNeil Pharmaceutical, Inc., a Johnson & Johnson subsidiary, that is prescribed to patients suffering from a bacterial infection of the lungs, skin, and urinary tract. Some patients who were prescribed Levaquin, and subsequently ingested the drug to treat their bacterial infection, experienced serious side effects.

The drug Levaquin has been known to inflict severe tendon damage, including tendon inflammation, tendonitis, joint immobility, and tendon rupture.

Minnesota Levaquin MDL and New Jersey Levaquin Mass Tort Plaintiffs Claim Serious Tendon Damage

By | Levaquin, Pharmaceutical litigation, Uncategorized

Minnesota Levaquin MDL and New Jersey Levaquin Mass Tort Plaintiffs Claim Serious Tendon DamageLevaquin, a drug manufactured by a Johnson & Johnson subsidiary – OrthoMcNeil Pharmaceutical, Inc. – is the topic of several lawsuits around the country that have since been consolidated into a Multi-District Litigation based in Minnesota. A mass tort litigation has been arranged in a New Jersey court.

Levaquin is a drug used to treat bacterial infections occurring in the lungs, urinary tract, skin, and other areas of the body. It soon became apparent that Levaquin was the cause of serious and painful side effects, primarily targeting patients’ tendons. Plaintiffs in the Minnesota MDL and the New Jersey mass tort litigation claim that Levaquin caused tendonitis, tendon rupture, joint immobility, and other joint complications.

As a result of increasing adverse event reports filed with the U.S. Food and Drug Administration (FDA), OrthoMcNeil was ordered to update Levaquin’s label with information regarding Levaquin tendon damage.

According to court minutes from a Status Conference held in the U.S. District Court for the District of Minnesota on December 4, 2012, the parties involved in the MDL are currently in negotiations relating to a three phase settlement. The goal of the settlement negotiations is to have the terms of the settlement defined early this year.

One case in the Minnesota Levaquin MDL is set to go to trial on March 5, 2013. Prior to that date, as outlined in the Status Conference court minutes, the Defense intends to put a number of motions in limine, and in particular the Defense is aiming to exclude expert testimony provided by a doctor. A ruling has not yet been made about the Defense’s request to put motions in limine.

The next Status Conference for the Minnesota Levaquin MDL is scheduled for January 8, 2013.

As detailed in an updated case document released in mid-December 2012, there are currently 1,835 cases pending in the New Jersey Levaquin mass tort litigation. The most recent case filed with the New Jersey court was done so on December 10, 2012. Bellwether trials in the New Jersey court have been scheduled for June of this year.

If you or a loved one has experienced one or more of the serious side effects linked to the use of Levaquin, such as tendonitis, tendon rupture, or other tendon damage, lawyers at Carey Danis & Lowe can help you and your loved one win the compensation for such an undeserved amount of suffering, pain, and losses.

Our experienced pharmaceutical product liability trial lawyers understand the importance of holding pharmaceutical giants like Johnson & Johnson and OrthoMcNeil Pharmaceutical, Inc. responsible for putting defective drugs onto the market. We work closely with our clients in Levaquin lawsuits to win them the justice they so rightfully deserve.

To file a Levaquin lawsuit, contact a lawyer at Carey Danis & Lowe today by calling 800.721.2519.

Levaquin Lawsuit Recently Filed in Minnesota

By | Levaquin, Pharmaceutical litigation, Uncategorized

Published August 30, 2012 on LawsuitInformation.org

In early August, a Minnesota man filed a lawsuit against the manufacturer of Levaquin, Ortho McNeil Janssen Pharmaceuticals, a manufacturing unit of Johnson & Johnson. The man, Richard Johnson, stated in his pharmaceutical liability claim that the drug’s manufacturer neglected to supply adequate health warnings about the use of Levaquin and its link to tendon rupture.

Johnson suffered a rotator cuff tear, and has linked his use of Levaquin, an antibiotic prescribed to treat urinary tract infections, pneumonia, meningitis, cellulitis, and respiratory tract infections, to the damage inflicted on his rotator cuff tendons. Johnson’s case now becomes an addition to the products liability litigation regarding Levaquin in the District Court, District of Minnesota in Minneapolis. Levaquin lawsuits have been combined into multidistrict litigation (MDL) in Minnesota.

In 2008, in response to reports of severe tendon damage and tendonitis, the U.S. Food and Drug Administration (FDA) required manufacturers of fluoroquinolones, a category of antibiotic which includes Levaquin, update the black box label on their drugs to include a detailed and complete warning about the risk of life-altering tendon deterioration and rupture. It has been reported that the manufacturer of Levaquin made a paltry effort at such drug transparency in an attempt to increase drug distribution and profits.

Drug and Medical Device Cases To Look for in Your Practice

By | Defective Medical Device litigation, Pharmaceutical litigation, Uncategorized

Published May 15, 2012 on InjuryBoard

It is hard to keep track of all of the information we get daily about various drugs and devices. Which ones are potential cases? Who can review them for me?

Here is a list of cases that we are reviewing, and can assist you on. It is not exhaustive.

Depuy Hip Replacements: These hips were installed in thousands of patients without adequate testing. It turns out that the metal components degrade and leave dangerous levels of metal in the blood stream. They also are often ill fitting. In almost every case the replacement needs to be redone.

Actos: This is a diabetes medication that was known to cause bladder cancer.

Zicam: This is a nasal inhaler for colds that causes loss of taste and smell.

Flouroquinolones (Cipro, Levaquin, Avelox): These drugs are known to cause tendon ruptures. The manufacturers have warned since 2009 that they should be used sparingly and only when necessary, yet some doctors continue to overprescribe the drugs. These are now brought by us as medical malpractice claims.

Medtronic Pacemaker Leads: The leads on some of these pacemakers are defective, and can cause death and even when discovered in time can be very difficult to replace.

SSRIs and Birth Defects: Some SSRI medications have been linked to birth defects, and may be actionable.

Defective Drugs Trigger Avalanche of Lawsuits

By | Pharmaceutical litigation, Uncategorized

Published April 20, 2012 on LawsuitInformation.org

A lawsuit against drug manufacturer Pfizer is simmering in St. Louis, bouncing between state and federal courts while judges decide who will have the pleasure of trying the case. The class action suit is on behalf of 21 mothers who contend that their children were born with birth defects caused by the antidepressant drug Zoloft, which is made by Pfizer.

This particular lawsuit was filed in February and is still in its early stages. However, it is but the latest addition to a disturbing number of prescription drugs which are the subject of litigation due to the serious side effects they cause. Antidepressants in particular have been under fire for causing severe birth defects, up to and including fetal death.

Every drug has side effects, and consumers have the right to frank and accurate descriptions of the risks involved before they start taking a pharmaceutical product. Unfortunately, the trend has been for marketers and manufacturers to downplay or cover up the potential side effects of their wares, with sometimes disastrous results.

“Some haphazardly constructed and advertised medications are contributing to ailments that are much more difficult to overcome than the patient’s original health problem,” says John Bisnar, an attorney at California personal injury firm Bisnar Chase. “As more drug defect victims continue to come forward with debilitating injuries, more pharmaceutical manufacturing companies are being hit with large settlements and verdicts.”

Crippling Side Effects

“If you take medication, avoiding side effects is nearly impossible,” Bisnar says. “Mild side effects are of little concern, but what may seem to be a mild side effect may turn out to be something that is life-threatening. The best way to tell which is which is by keeping track of the medications that have received numerous complaints across the globe.”

A number of medications are currently the subject of lawsuits:

  • Reglan, an acid reflux drug, can cause Tardive Dyskinesia, a permanent neurological disorder characterized by involuntary facial and limb movements.
  • Actos is a diabetes medicine that has been linked to bladder cancer.
  • The painkiller Darvocet was removed from the market in 2010 after the FDA found that use of the drug can lead to heart problems and death.
  • A drug used to treat seizures and migraines, Topamax, has been found to cause birth defects like cleft palate.
  • Use of Effexor, an antidepressant, can cause heart and lung defects in babies.
  • People using Accutane to treat severe acne could be subject to liver disease, depression, ulcerative colitis and birth defects.
  • Fosamax is a drug used to treat osteoporosis but can cause a number of side effects, such as rashes, numbness, loose teeth, jaw collapse and fractured femurs.
  • The antibiotic Levaquin has been implicated in tendon ruptures. A 76-year-old plaintiff from Minnesota won $1.8 million from manufacturer Johnson & Johnson in 2010, and many more suits are pending.
  • Depakote, used to treat manic depression, has been found to cause a range of birth defects, some mild but others as serious as skeletal deformation and fetal death.
  • Another antidepressant, Lexapro, can also cause abdominal, cranial and heart-related birth defects.
  • Paxil, yet another drug used to treat depression, is linked to a laundry list of side effects for adults and newborns, all the way from dry mouth and gas to seizures, bleeding and serious heart and lung defects. As of July 2010 manufacturer GlaxoSmithKline had already spent $1 billion to resolve 800 claims of birth defects.
  • The diabetes drug Avandia, another GlaxoSmithKline product, has sparked more than 13,000 lawsuits due to its propensity for causing heart attacks.
  • A blood-thinning product called Plavix, designed to reduce the risk of heart attacks, has come under fire for actually increasing the chance that patients could suffer from heart attacks, strokes or other ailments.
  • A lawsuit over the hormone replacement drug Prempro was settled last fall after Pfizer faced a $73 million verdict for three women who said the drug gave them breast cancer. Nearly a thousand other claims are still pending.
  • Yaz, a relatively new hormonal birth control product, is alleged to cause heart attacks, strokes, blood clots, pulmonary embolisms, and gallbladder disease.
  • Cholesterol medicine Zocor is facing lawsuits claiming that the drug causes a deadly muscle disease called Rhabdomyolysis.